{"name":"Zhejiang Huahai Pharmaceutical Co., Ltd.","slug":"zhejiang-huahai-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Duloxetine Hydrochloride Enteric Capsules","genericName":"Duloxetine Hydrochloride Enteric Capsules","slug":"duloxetine-hydrochloride-enteric-capsules","indication":"Major depressive disorder","status":"phase_3"},{"name":"Levomilnacipran Hydrochloride Extended-Release Capsules","genericName":"Levomilnacipran Hydrochloride Extended-Release Capsules","slug":"levomilnacipran-hydrochloride-extended-release-capsules","indication":"Major depressive disorder","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Hypidone Hydrochloride tablets","genericName":"Hypidone Hydrochloride tablets","slug":"hypidone-hydrochloride-tablets","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Hypidone Hydrochloride tablets","genericName":"Hypidone Hydrochloride tablets","slug":"hypidone-hydrochloride-tablets","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Duloxetine Hydrochloride Enteric Capsules","genericName":"Duloxetine Hydrochloride Enteric Capsules","slug":"duloxetine-hydrochloride-enteric-capsules","phase":"phase_3","mechanism":"Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases levels of serotonin and norepinephrine in the central nervous system by blocking their reuptake at the presynaptic membrane.","indications":["Major depressive disorder","Generalized anxiety disorder","Diabetic peripheral neuropathic pain","Fibromyalgia","Chronic musculoskeletal pain"],"catalyst":""},{"name":"Levomilnacipran Hydrochloride Extended-Release Capsules","genericName":"Levomilnacipran Hydrochloride Extended-Release Capsules","slug":"levomilnacipran-hydrochloride-extended-release-capsules","phase":"phase_3","mechanism":"Levomilnacipran is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases levels of serotonin and norepinephrine in the brain by blocking their reuptake at the neuronal synapse.","indications":["Major depressive disorder"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNcHFmS3VieGZmcFcyc002QzdmazFyQ25XSHp3NWJPRDZyNTdJQ0VyYnF5QUhkWHNLaVcydldjZXFjbGRfNmF4VE9maEJXZWZyeW5BSlhNY1o3d1VId1M5cDZGUmZBUzl3U2dobVdPN0ZaaHZUZXFxaFRfZVRnSUpxT2NkVXZGVE4tRUt0am0tUGlhY0E0eWNDcWpFMGJVX3lIcUZTY2V4cE1ybEFVSlEzN0ExWm85cFRSWC1tWg?oc=5","date":"2024-10-02","type":"trial","source":"Bloomberg.com","summary":"Chinese Drugmaker on Trial for Contamination Still Sells in US - Bloomberg.com","headline":"Chinese Drugmaker on Trial for Contamination Still Sells in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNRVYwSzRUckJ2VXhEcG5Eclpib3pxNUhkT2FIN2tZdldubXlnQnh6VE44YV9lUmMxYnN1eHBrNWlpZGJjWnJKeUpiM2tHQUlxaVlZU2NfODhUbTdQQ2tkX2g3RWxmSGxvMy1GajNMcDA4dXY2NGdsTVIxR1FKUThjQkowRmRoN0gxRWZaUFNBZGdsY3MxM2FFQ2pYaVhYXzlDdzh2VUNGWUd6VWN4UFRSQjlOTmxVbjVjaDhfVVI2bERYU05VeXA5TDJSLWJNRE90Vm9Z?oc=5","date":"2022-05-07","type":"pipeline","source":"fortune.com","summary":"‘Please pay attention’: Scientist flagged heart-pill toxins early on - fortune.com","headline":"‘Please pay attention’: Scientist flagged heart-pill toxins early on","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQMHVFU3pvVi05UlJOYnhhVTJDQU1HeFBsaENBelRKQXdRamZIVlEwVUJBT2VYaUQtbE1sNzlNWDdIVkRXaUtCU0RMX29EWE9wWElRMWM5X0lTaXQ1bDk0Y3hKRy1UeUIxUm0zMWNLNURMOFBhbVRXUzd1NnUzVDRIYWYzZDl4cENSa2djSUxKaWdLdHh1YlpzY0Q1WTc?oc=5","date":"2022-01-20","type":"regulatory","source":"Generics and Biosimilars Initiative","summary":"FDA closes Zhejiang Huahai Pharmaceutical warning letter - Generics and Biosimilars Initiative","headline":"FDA closes Zhejiang Huahai Pharmaceutical warning letter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNTktObVVMQXZ2QlMwWVlVNFBPakZkSEVwTDMtaVFPalBrQVA1dDhfSHpobnVMWG1JcFRCSXJubkFFRUtQb2R6UFEtaEJXLUVodnRySENkNXVvNjAteUg0NUhldmVDN3h4NlowTm5PbmxkYTlRS0dIUmlGTjA3RU90Y0tSWEtEaGN1LWsxSHJPaXBkbHZ2WmRmZzAzd0FHaTJ5X3BXeE1XQnpQV0IxbnRlb0xIdHdLa2gwRm5vaG9uMlptZU4t?oc=5","date":"2021-11-15","type":"regulatory","source":"Fierce Pharma","summary":"After triggering a global valsartan recall 3 years ago, Chinese drug manufacturer overcomes FDA warning letter - Fierce Pharma","headline":"After triggering a global valsartan recall 3 years ago, Chinese drug manufacturer overcomes FDA warning letter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQbnlHUmYtV0F4UHhRRXhzRlRHYW0xeWt2V09BbElIZUY3WGUtRnNTdldzLW9LVXFxNC1iMV9WWXhZcjZNa2xFeG9XRW05cGR6WGdFRmpZQndMTktVbXN4ajJmbU5Bck53OV9taXFWRU04RmV4QzlIaGNVdGU5YTFoXzJKdzVScWdha0xuYVlndGh6dmM1ZV9QVmNB?oc=5","date":"2019-06-27","type":"pipeline","source":"The People's Pharmacy","summary":"A New Carcinogen DMF Discovered in Valsartan BP Pills - The People's Pharmacy","headline":"A New Carcinogen DMF Discovered in Valsartan BP Pills - The People's Pharmacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPcnlfa05ydFhiRGZTWVBlcERWQWYydWxiclpzZUgwT25VRWdfU3dFUnhSem1HSC0xNTI1NW9HVGlyM2RDbTVWYkpvYkI0dHlwaFJWRFFEVG0tU0o3RkJlNnY3SjUyZnktM3lyODktVm9MY1RqVVdBTmgzbnhnT2ZhTE02WXA4OTZQT0E?oc=5","date":"2019-01-07","type":"pipeline","source":"Managed Healthcare Executive","summary":"Blood pressure drug recall expands - Managed Healthcare Executive","headline":"Blood pressure drug recall expands","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQdTd1SnpKNk1mMTBsOW1qV2ZJM29OaHhWcVBmNVFCMFlKVnBWaURwMzJFM2hUMEZ4WUd2S0c1OE1LYVBWV2lzWC1ZYU1WWUh6YVZrQm1iTUhMZVEzQ2JnT1pQYi1aTmtYRy13ZGtQaEFfNTVnTExUUVVrYU9FTTk4OU02eFZSeUxMTnVaUkJRcmx1dmdk?oc=5","date":"2018-12-11","type":"regulatory","source":"pharmacytimes.com","summary":"Valsartan Recall: FDA Issues Warning to API Manufacturer - pharmacytimes.com","headline":"Valsartan Recall: FDA Issues Warning to API Manufacturer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPZ1BRaVZwZUo1enluek1ONGxkai1jZTVxTFBpdFh2QjFQRzM2NHMwYmVFTm1ZcDRseFNuSEtXOHo5TnJqaEVRdzl2YjlFbFZRandNUXBnYlMtRFNEeW9nY28tckhvUjM3UEp6ZEhwVW9aQ1BuMjk3RWZJX1NBVW4wQmFWSU0zUnVfaEVtc3JiR1Y5Z3lSTTBobVluUWYtYmkyRmp1V0hSX1FIX19NYm5MRmNzZUFVSmlMSXVLV0J0dmxia0Y0VzFqNQ?oc=5","date":"2018-11-19","type":"regulatory","source":"Yicai Global","summary":"China's Zhejiang Huahai Pharma Receives US Regulatory Approval for Its Cardiovascular Generic Drug - Yicai Global","headline":"China's Zhejiang Huahai Pharma Receives US Regulatory Approval for Its Cardiovascular Generic Drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNQUFiTTd5d0ZydDhMR0U4bzhEVE9NeUFYaGhhMjF0M3JYc3hYZkZxbXRpMFZzVmlqb3Vla1l3TnV1THJnTWdjRGF1UXVhRDZIR29JekM1ZjU2Q3k0d01FalBEMEt4b2RsZVlrLS1UekVNam5NbzlVdzNFNUV3SEhNTGZuQXR6Zw?oc=5","date":"2018-09-20","type":"pipeline","source":"Pharmaceutical Technology","summary":"A summer of manufacturing disasters for Chinese pharma - Pharmaceutical Technology","headline":"A summer of manufacturing disasters for Chinese pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE5EX2pTV19GdmxHbjZxOTk2TzJiMEhmN3V5S0cyTi0wUTZleVpDUlVLS3ViQm03UGkyN3NSbDlmM3FHY3BRUm1RNExVTldXX0hvYlFTOWpXVzJ2Umw2dV9WcGFFaVRZakt6c2tCVHBlV2gtZXpVZmZfUA?oc=5","date":"2018-07-25","type":"regulatory","source":"American Academy of Family Physicians | AAFP","summary":"FDA Issues Recall Alert for Some Drugs Containing Valsartan - American Academy of Family Physicians | AAFP","headline":"FDA Issues Recall Alert for Some Drugs Containing Valsartan - American Academy of Family Physicians | AAFP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBRTHdFUEJ2QWprdEJzRVdEUWV3MnEzdmdSUEFVUjZzY3NpVHJuMG5oRWhMRThrczREMjBheVA5SVV2aUdEUEJReXROaG04TTBQMUsxdXhzNHkyUGE2M1hLbjZNdkpwd3M?oc=5","date":"2018-07-17","type":"pipeline","source":"Time Magazine","summary":"3 Companies Recall Blood Pressure Medications Over Cancer Fears - Time Magazine","headline":"3 Companies Recall Blood Pressure Medications Over Cancer Fears","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFA4bUUxT25va2dlWmQwV3RjdUY3ckluX0FZa3hTam5SbGVjMktnU1ZQWlJ5aHFSRGd3cDVUSktpVUc2aGFtaG9sajJIWFRZeUVPYzVDb1RpY1NSWlh4bTZKNEVoZHpKT1pVLW9sa0FNU3hvY3VRSnhXRg?oc=5","date":"2018-02-06","type":"pipeline","source":"jetro.go.jp","summary":"Leading Chinese drug maker Zhejiang Huahai Pharmaceutical establishes corporation in Nagoya - jetro.go.jp","headline":"Leading Chinese drug maker Zhejiang Huahai Pharmaceutical establishes corporation in Nagoya","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":1,"phase_3":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}